BMS Archive

Plant · Scientific monograph

Betula pendula

Silver birch

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Traditional urinary use

Research overview

Historical use

Birch leaf has an EMA traditional-use conclusion for increasing urine output to support flushing in minor urinary complaints. The monograph covers B. pendula, B. pubescens and hybrids, so evidence is not always attributable to B. pendula alone [1].

Modern research context

EMA found insufficient clinical-trial evidence for a well-established use; its conclusion rests on long-standing traditional use [1]. Other indexed studies include nonclinical or food-beverage investigations and do not establish treatment of urinary infection [2,3].

Adverse effects

EMA reports gastrointestinal symptoms and allergic reactions with frequency unknown [1].

Contraindications

Avoid in birch-leaf/pollen hypersensitivity and in conditions requiring fluid restriction, including severe heart or kidney disease, as specified by EMA [1].

Clinical and phytochemical data

Used part

Leaf, usually as comminuted/powdered material or dry/liquid extract; scope is leaf-specific [1].

Primary active compounds

    Mechanism of action

    The EMA traditional-use assessment does not establish a clinical mechanism. Nonclinical anti-adhesive findings are not proof of human efficacy [1,2]. The cited human studies do not characterize an active compound or establish constituent-specific activity.

    Pharmacokinetics

    Absorption

    Human PK data for birch-leaf medicinal products were not identified; the beverage study does not establish clinical PK for medicines [2].

    Distribution

    Not characterized.

    Metabolism

    Not characterized.

    Excretion

    No human drug-PK data identified; diuresis is the traditional-use rationale, not a measured medicinal PK endpoint [1].

    Safety and interactions

    Drug interactions

    No species-specific clinical interaction study identified; EMA advises appropriate hydration and lists contraindications [1].

    Toxicity

    Human long-term toxicity is not established; reported adverse effects are limited to the EMA summary [1].

    Special precautions

    Pregnancy

    EMA indicates use only for adults and adolescents over 12; pregnancy/lactation evidence is insufficient [1].

    Lactation

    Insufficient data; EMA advises consultation for medicinal use during lactation [1].

    Hepatic impairment

    No impairment-specific PK or safety data; EMA contraindicates use where fluid restriction is recommended [1].

    Renal impairment

    Same as hepatic impairment; severe renal disease/fluid restriction is a contraindication [1].

    Sources and references

    1. [1] EMA/HMPC. European Union herbal monograph on Betula pendula Roth, Betula pubescens Ehrh. and hybrids, folium. EMA/482160/2015.
    2. [2] Roszko M et al. Evaluating birch leaf tea as a functional herbal beverage: Beneficial impact on the urinary tract, and metabolism in human organism. Food Research International. 2024. PMID: 38876582. DOI: 10.1016/j.foodres.2024.114481.
    3. [3] Emilia Okragla, Milena Chraniuk, Lidia Wolska. Microtox test as a tool to assess antimicrobial properties of herbal infusions used in urinary tract infections. Acta Poloniae Pharmaceutica. 2017;74(3):895–901. PMID: 29513959.

    Additional source links

    Continue browsing